Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » Former NCI Bioinformatics Head Joins Genaissance

Former NCI Bioinformatics Head Joins Genaissance

Apr 08, 1999
Premium

NEW HAVEN, Conn.--Genaissance Pharmaceuticals, a company that exploits gene variation for the pharmaceutical industry, named Joel Claiborne Stephens as director of population genomics. Stephens, who has headed the bioinformatics group at the US National Cancer Institute since 1990, will direct the application of gene haplotypes for more effective clinical trails and the enhancement of drugs in the market, Genaissance said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Pause Recommended

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

Science and a Side of Diplomacy

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

New Studies of B.1.1.7

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

PNAS Papers on Acute Kidney Injury, Parental Expression in Horse Placenta, Sea Urchin Microbes

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.

Apr
28
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Integrative Analysis of Single-Cell Omics and Imaging Data

Sponsored by
Akoya Biosciences

Single-cell omics assays have become essential tools for identifying and characterizing cell types and states of complex tissues. While each single-modality assay reveals distinctive features about the sequenced cells, true multiomics assays are still in the early stage of development. 

May
04
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Transcriptome-Guided Analysis of Highly Multiplexed Immunohistochemistry Images

Sponsored by
Akoya Biosciences

Recently developed technologies for digital imaging and highly multiplexed immunohistochemistry (mIHC) advancing the field of histology into a quantitative era, allowing for more complex descriptions of tissue architecture.

May
06
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Enriching Spatial Proteomic Data with Parallel CITE-seq Analysis Elucidates Multiomic Changes with Aging

Sponsored by
Akoya Biosciences

Integrating complementary data sets provides a powerful tool to study complex biological processes.

May
11
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Panel Discussion: Analysis Strategies for Enriching Single-Cell Spatial Phenotyping Data

Sponsored by
Akoya Biosciences

Our expert panelists will review their own strategies for addressing the challenges of integrative multiomic analysis and will share best practices for this rapidly evolving field.

What's Popular?

In Informatics

  1. Sanford Health Looks to Improve Rare Disease Dx, Research With Congenica Technology

    Premium

  2. Long-Read Genome Assemblies Have 'Blind Spots' for Structural Variant Detection

    Premium

  3. Congenica Strikes Asian Distribution Deal With Camtech Diagnostics

  4. Cleveland Clinic, IBM Look to Future With Quantum Computing Collaboration

    Premium

  5. Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.